Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for thigh pain sufferers: radiofrequency ablation outperforms steroid injections?

NCT ID NCT06683924

Symptom relief Sponsor: Ankara City Hospital Bilkent Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two treatments for meralgia paresthetica, a condition causing pain, numbness, and tingling in the outer thigh. Researchers compared pulsed radiofrequency ablation (using heat to calm the nerve) with steroid injections in 22 adults who did not get relief from simple measures like avoiding tight belts or losing weight. The goal was to see which treatment better reduces pain and nerve symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

22 people

The number who actually took part.

Started

Oct 2024

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with numbness, tingling and pain in the anterolateral thigh region * Patients with edematous LFCN observed on ultrasound and diagnosed with MP and with complaints resistant to conservative treatment * Being literate Exclusion Criteria: * History of lumbar discopathy or history of discopathy surgery * Cardiac pacemaker * History of bilateral hip, knee, foot and lumbar region fractures * History of previous hip and knee surgery * Fixed joint contracture in the lower extremity * History of malignancy and chemotherapy or radiotherapy * Presence of any neuromuscular disease * Progressive or non-progressive central and peripheral nervous system disease * Patients in pregnancy and lactation * Bleeding diathesis, INR\>1.2 * Uncontrolled diabetes or other serious comorbidities * Allergy to drugs or materials used * Local infections or sepsis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Meralgia paresthetica are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

femoral neuropathy meralgia paresthetica

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Meralgia paresthetica

Contacts and locations

Locations

  • Ankara Bilkent City Hospital

    Ankara, 06800, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.